Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

The Lancet

Volumn 391, Issue 10125, 2018, Pages 1023-1075

  Allemani, Claudia ^a   Matsuda, Tomohiro ^b   Di Carlo, Veronica ^a   Harewood, Rhea ^a   Matz, Melissa ^a   Nikšić, Maja ^a   Bonaventure, Audrey ^a   Valkov, Mikhail ^c   Johnson, Christopher J ^d   Estève, Jacques ^e   Ogunbiyi, Olufemi J ^f   Azevedo e Silva, Gulnar ^g   Chen, Wan Qing ^h   Eser, Sultan ⁱ   Engholm, Gerda ^j   Stiller, Charles A ^k   Monnereau, Alain ^l,m   Woods, Ryan R ⁿ   Visser, Otto ^o   Lim, Gek Hsiang ^p   Aitken, Joanne ^q   Weir, Hannah K ^r   Coleman, Michel P ^a   Bouzbid, S ^s   Hamdi Cherif M ^s   Zaidi, Z ^s   Meguenni, K ^s   Regagba, D ^s   Bayo, S ^s   Cheick Bougadari, T ^s   Manraj, S S ^s   Bendahhou, K ^s   Fabowale, A ^s   Bradshaw, D ^s   Somdyala, N I M ^s   Kumcher, I ^s   Moreno, F ^s   Calabrano, G H ^s   Espinola, S B ^s   Carballo Quintero, B ^s   Fita, R ^s   Diumenjo, M C ^s   Laspada, W D ^s   Ibanez S G ^s   Lima, C A ^s   De Souza, P C F ^s   Del Pino, K ^s   Laporte, C ^s   Curado, M P ^s   de Oliveira, J C ^s   Veneziano, C L A ^s   Veneziano, D B ^s   Latorre, M R D O ^s   Tanaka, L F ^s   Rebelo, M S ^s   Santos, M O ^s   Galaz, J C ^s   Aparicio Aravena, M ^s   Sanhueza Monsalve, J ^s   Herrmann, D A ^s   Vargas, S ^s   Herrera, V M ^s   Uribe, C J ^s   Bravo, L E ^s   Garcia, L S ^s   Arias Ortiz, N E ^s   Morantes, D ^s   Jurado, D M ^s   Yepez Chamorro M C ^s   Delgado, S ^s   Ramirez, M ^s   Galan Alvarez Y H ^s   Torres, P ^s   Martinez Reyes F ^s   Jaramillo, L ^s   Quinto, R ^s   Castillo, J ^s   Mendoza, M ^s   Cueva, P ^s   Yepez J G ^s   Bhakkan, B ^s   Deloumeaux, J ^s   Joachim, C ^s   Macni, J ^s   Carrillo, R ^s   Shalkow Klincovstein, J ^s   Rivera Gomez, R ^s   Poquioma, E ^s   Tortolero Luna, G ^s   Zavala, D ^s   Alonso, R ^s   Barrios, E ^s   Eckstrand, A ^s   Nikiforuk, C ^s   Noonan, G ^s   Turner, D ^s   Kumar, E ^s   Zhang, B ^s   McCrate, F R ^s   Ryan, S ^s   MacIntyre, M ^s   Saint Jacques, N ^s   Nishri, D E ^s   McClure, C A ^s   Vriends, K A ^s   Kozie, S ^s   Stuart Panko, H ^s   Freeman, T ^s   George, J T ^s   Brockhouse, J T ^s   O'Brien, D K ^s   Holt, A ^s   Almon, L ^s   Kwong, S ^s   Morris, C ^s   Rycroft, R ^s   Mueller, L ^s   Phillips, C E ^s   Brown, H ^s   Cromartie, B ^s   Schwartz, A G ^s   Vigneau, F ^s   Levin, G M ^s   Wohler, B ^s   Bayakly, R ^s   Ward, K C ^s   Gomez, S L ^s   McKinley, M ^s   Cress, R ^s   Green, M D ^s   Miyagi, K ^s   Ruppert, L P ^s   Lynch, C F ^s   Huang, B ^s   Tucker, T C ^s   Deapen, D ^s   Liu, L ^s   Hsieh, M C ^s   Wu, X C ^s   Schwenn, M ^s   Gershman, S T ^s   Knowlton, R C ^s   Alverson, G ^s   Copeland, G E ^s   Bushhouse, S ^s   Rogers, D B ^s   Jackson Thompson, J ^s   Lemons, D ^s   Zimmerman, H J ^s   Hood, M ^s   Roberts Johnson, J ^s   Rees, J R ^s   Riddle, B ^s   Pawlish, K S ^s   Stroup, A ^s   Key, C ^s   Wiggins, C ^s   Kahn, A R ^s   Schymura, M J ^s   Radhakrishnan, S ^s   Rao, C ^s   Giljahn, L K ^s   Slocumb, R M ^s   Espinoza, R E ^s   Khan, F ^s   Aird, K G ^s   Beran, T ^s   Rubertone, J J ^s   Slack, S J ^s   Garcia, L ^s   Rousseau, D L ^s   Janes, T A ^s   Schwartz, S M ^s   Bolick, S W ^s   Hurley, D M ^s   Whiteside, M A ^s   Miller Gianturco, P ^s   Williams, M A ^s   Herget, K ^s   Sweeney, C ^s   Johnson, A T ^s   Keitheri Cheteri, M B ^s   Migliore Santiago, P ^s   Blankenship, S E ^s   Farley, S ^s   Borchers, R ^s   Malicki, R ^s   Espinoza, J R ^s   Grandpre, J ^s   Wilson, R ^s   Edwards, B K ^s   Mariotto, A ^s   Lei, Y ^s   Wang, N ^s   Chen, J S ^s   Zhou, Y ^s   He, Y T ^s   Song, G H ^s   Gu, X P ^s   Mei, D ^s   Mu, H J ^s   Ge, H M ^s   Wu, T H ^s   Li, Y Y ^s   Zhao, D L ^s   Jin, F ^s   Zhang, J H ^s   Zhu, F D ^s   Junhua, Q ^s   Yang, Y L ^s   Jiang, C X ^s   Biao, W ^s   Wang, J ^s   Li, Q L ^s   Yi, H ^s   Zhou, X ^s   Dong, J ^s   Li, W ^s   Fu, F X ^s   Liu, S Z ^s   Chen, J G ^s   Zhu, J ^s   Li, Y H ^s   Lu, Y Q ^s   Fan, M ^s   Huang, S Q ^s   Guo, G P ^s   Zhaolai, H ^s   Wei, K ^s   Zeng, H ^s   Demetriou, A V ^s   Mang, W K ^s   Ngan, K C ^s   Kataki, A C ^s   Krishnatreya, M ^s   Jayalekshmi, P A ^s   Sebastian, P ^s   Nandakumar, A ^s   Malekzadeh, R ^s   Roshandel, G ^s   Keinan Boker, L ^s   Silverman, B G ^s   Ito, H ^s   Nakagawa, H ^s   Sato, M ^s   Tobori, F ^s   Nakata, I ^s   Teramoto, N ^s   Hattori, M ^s   Kaizaki, Y ^s   Moki, F ^s   Sugiyama, H ^s   Utada, M ^s   Nishimura, M ^s   Yoshida, K ^s   Kurosawa, K ^s   Nemoto, Y ^s   Narimatsu, H ^s   Sakaguchi, M ^s   Kanemura, S ^s   Naito, M ^s   Narisawa, R ^s   Miyashiro, I ^s   Nakata, K ^s   Sato, S ^s   Yoshii, M ^s   Oki, I ^s   Fukushima, N ^s   Shibata, A ^s   Iwasa, K ^s   Ono, C ^s   Nimri, O ^s   Jung, K W ^s   Won, Y J ^s   Alawadhi, E ^s   Elbasmi, A ^s   Ab Manan, A ^s   Adam, F ^s   Sanjaajmats, E ^s   Tudev, U ^s   Ochir, C ^s   Al Khater, A M ^s   El Mistiri, M M ^s   Teo, Y Y ^s   Chiang, C J ^s   Lee, W C ^s   Buasom, R ^s   Sangrajrang, S ^s   Kamsa ard, S ^s   Wiangnon, S ^s   Daoprasert, K ^s   Pongnikorn, D ^s   Leklob, A ^s   Sangkitipaiboon, S ^s   Geater, S L ^s   Sriplung, H ^s   Ceylan, O ^s   Kog I ^s   Dirican, O ^s   Kose T ^s   Gurbuz, T ^s   Karasahin F E ^s   Turhan, D ^s   Aktas U ^s   Halat, Y ^s   Yakut, C I ^s   Altinisik, M ^s   Cavusoglu, Y ^s   Turkkoylu A ^s   Ucuncu N ^s   Hackl, M ^s   Zborovskaya, A A ^s   Aleinikova, O V ^s   Henau, K ^s   Van Eycken, L ^s   Valerianova, Z ^s   Yordanova, M R ^s   Sekerija M ^s   Dusek L ^s   Zvolsky M ^s   Storm, H ^s   Innos, K ^s   Magi M ^s   Malila, N ^s   Seppa K ^s   Jegu J ^s   Velten, M ^s   Cornet, E ^s   Troussard, X ^s   Bouvier, A M ^s   Guizard, A V ^s   Bouvier, V ^s   Launoy, G ^s   Arveux, P ^s   Maynadie M ^s   Mounier, M ^s   Woronoff, A S ^s   Daoulas, M ^s   Robaszkiewicz, M ^s   Clavel, J ^s   Goujon, S ^s   Lacour, B ^s   Baldi, I ^s   Pouchieu, C ^s   Amadeo, B ^s   Coureau, G ^s   Orazio, S ^s   Preux, P M ^s   Rharbaoui, F ^s   Marrer, E ^s   Tretarre B ^s   Colonna, M ^s   Delafosse, P ^s   Ligier, K ^s   Plouvier, S ^s   Cowppli Bony, A ^s   Molinie F ^s   Bara, S ^s   Ganry, O ^s   Lapotre Ledoux B ^s   Grosclaude, P ^s   Bossard, N ^s   Uhry, Z ^s   Bray, F ^s   Pineros M ^s   Stabenow, R ^s   Wilsdorf Kohler H ^s   Eberle, A ^s   Luttmann, S ^s   Lohden I ^s   Nennecke, A L ^s   Kieschke, J ^s   Sirri, E ^s   Emrich, K ^s   Zeissig, S R ^s   Holleczek, B ^s   Eisemann, N ^s   Katalinic, A ^s   Asquez, R A ^s   Kumar, V ^s   Petridou, E ^s   Olafsdottir E J ^s   Tryggvadottir L ^s   Clough Gorr, K ^s   Walsh, P M ^s   Sundseth, H ^s   Mazzoleni, G ^s   Vittadello, F ^s   Coviello, E ^s   Cuccaro, F ^s   Galasso, R ^s   Sampietro, G ^s   Giacomin, A ^s   Magoni, M ^s   Ardizzone, A ^s   D'Argenzio, A ^s   Castaing, M ^s   Grosso, G ^s   Lavecchia, A M ^s   Sutera Sardo, A ^s   Gola, G ^s   Gatti, L ^s   Ricci, P ^s   Ferretti, S ^s   Serraino, D ^s   Zucchetto, A ^s   Celesia, M V ^s   Filiberti, R A ^s   Pannozzo, F ^s   Melcarne, A ^s   Quarta, F ^s   Russo, A G ^s   Carrozzi, G ^s   Cirilli, C ^s   Cavalieri d'Oro, L ^s   Rognoni, M ^s   Fusco, M ^s   Vitale, M F ^s   Usala, M ^s   Cusimano, R ^s   Mazzucco, W ^s   Michiara, M ^s   Sgargi, P ^s   Boschetti, L ^s   Borciani, E ^s   Seghini, P ^s   Maule, M M ^s   Merletti, F ^s   Tumino, R ^s   Mancuso, P ^s   Vicentini, M ^s   Cassetti, T ^s   Sassatelli, R ^s   Falcini, F ^s   Giorgetti, S ^s   Caiazzo, A L ^s   Cavallo, R ^s   Cesaraccio, R ^s   Pirino, D R ^s   Contrino, M L ^s   Tisano, F ^s   Fanetti, A C ^s   Maspero, S ^s   Carone, S ^s   Mincuzzi, A ^s   Candela, G ^s   Scuderi, T ^s   Gentilini, M A ^s   Piffer, S ^s   Rosso, S ^s   Barchielli, A ^s   Caldarella, A ^s   Bianconi, F ^s   Stracci, F ^s   Contiero, P ^s   Tagliabue, G ^s   Rugge, M ^s   Zorzi, M ^s   Beggiato, S ^s   Brustolin, A ^s   Berrino, F ^s   Gatta, G ^s   Sant, M ^s   Buzzoni, C ^s   Mangone, L ^s   Capocaccia, R ^s   De Angelis, R ^s   Zanetti, R ^s   Maurina, A ^s   Pildava, S ^s   Lipunova, N ^s   Vincerzevskiene I ^s   Agius, D ^s   Calleja, N ^s   Siesling, S ^s   Laronningen S ^s   Moller B ^s   Dyzmann Sroka, A ^s   Trojanowski, M ^s   Gozdz S ^s   Mezyk R ^s   Mierzwa, T ^s   Molong, L ^s   Rachtan, J ^s   Szewczyk, S ^s   Blaszczyk J ^s   Kepska K ^s   Koscianska B ^s   Tarocinska K ^s   Zwierko, M ^s   Drosik, K ^s   Maksimowicz, K M ^s   Purwin Porowska, E ^s   Reca, E ^s   Wojcik Tomaszewska J ^s   Tukiendorf, A ^s   Gradalska Lampart M ^s   Radziszewska, A U ^s   Gos, A ^s   Talerczyk, M ^s   Wyborska, M ^s   Didkowska, J A ^s   Wojciechowska, U ^s   Bielska Lasota, M ^s   Forjaz de Lacerda, G ^s   Rego, R A ^s   Bastos, J ^s   Silva, M A ^s   Antunes, L ^s   Laranja Pontes, J ^s   Mayer da Silva, A ^s   Miranda, A ^s   Blaga, L M ^s   Coza, D ^s   Gusenkova, L ^s   Lazarevich, O ^s   Prudnikova, O ^s   Vjushkov, D M ^s   Egorova, A G ^s   Orlov, A E ^s   Kudyakov, L A ^s   Pikalova, L V ^s   Adamcik, J ^s   Safaei Diba, C ^s   Primic Zakelj M ^s   Zadnik, V ^s   Larranaga N ^s   Lopez de Munain, A ^s   Herrera, A A ^s   Redondas, R ^s   Marcos Gragera, R ^s   Vilardell Gil, M L ^s   Molina, E ^s   Sanchez Perez M J ^s   Franch Sureda, P ^s   Ramos Montserrat, M ^s   Chirlaque, M D ^s   Navarro, C ^s   Ardanaz, E E ^s   Guevara, M M ^s   Fernandez Delgado R ^s   Peris Bonet, R ^s   Carulla, M ^s   Galceran, J ^s   Alberich, C ^s   Vicente Raneda, M ^s   Khan, S ^s   Pettersson, D ^s   Dickman, P ^s   Avelina, I ^s   Staehelin, K ^s   Camey, B ^s   Bouchardy, C ^s   Schaffar, R ^s   Frick, H ^s   Herrmann, C ^s   Bulliard, J L ^s   Maspoli Conconi, M ^s   Kuehni, C E ^s   Redmond, S M ^s   Bordoni, A ^s   Ortelli, L ^s   Chiolero, A ^s   Konzelmann, I ^s   Matthes, K L ^s   Rohrmann, S ^s   Broggio, J ^s   Rashbass, J ^s   Fitzpatrick, D ^s   Gavin, A ^s   Clark, D I ^s   Deas, A J ^s   Huws, D W ^s   White, C ^s   Montel, L ^s   Rachet, B ^s   Turculet, A D ^s   Stephens, R ^s   Chalker, E ^s   Phung, H ^s   Walton, R ^s   You, H ^s   Guthridge, S ^s   Johnson, F ^s   Gordon, P ^s   D'Onise, K ^s   Priest, K ^s   Stokes, B C ^s   Venn, A ^s   Farrugia, H ^s   Thursfield, V ^s   Dowling, J ^s   Currow, D ^s   Hendrix, J ^s   Lewis, C ^s   more..

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NATIONAL CANCER CENTER   (Japan)

^c NORTHERN STATE MEDICAL UNIVERSITY   (Russian Federation)

^d Cancer Data Registry of Idaho   (United States)

^e UNIVERSITÉ LYON 1   (France)

^f UNIVERSITY OF IBADAN   (Nigeria)

^g STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^h National Cancer Center   (China)

ⁱ BALIKESIR UNIVERSITY   (Turkey)

^j DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^k PUBLIC HEALTH ENGLAND   (United Kingdom)

^l INSTITUT BERGONIÉ   (France)

^m Network of French Cancer Registries (FRANCIM)   (France)

ⁿ BRITISH COLUMBIA CANCER AGENCY   (Canada)

^o Netherlands Comprehensive Cancer Organisation   (Netherlands)

^p National Registry of Diseases Office   (Singapore)

^q CANCER COUNCIL QUEENSLAND   (Australia)

^r CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^s NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; AUSTRALIA; BRAIN TUMOR; BREAST CANCER; CANADA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER SURVIVAL; CHINA; COLON CANCER; CUTANEOUS MELANOMA; DENMARK; ECUADOR; ESOPHAGUS CANCER; FINLAND; GEOGRAPHIC DISTRIBUTION; GLOBAL DISEASE BURDEN; GROUPS BY AGE; HUMAN; ICELAND; JAPAN; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; NEW ZEALAND; NORWAY; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; SOUTH KOREA; STOMACH CANCER; SURVIVAL TIME; SWEDEN; TAIWAN; TREND STUDY; UNITED STATES; UTERINE CERVIX CANCER; HEALTH SURVEY; MORTALITY; NEOPLASM; PATHOLOGY; REGISTER; SURVIVAL RATE;

HUMANS; NEOPLASMS; POPULATION SURVEILLANCE; REGISTRIES; SURVIVAL RATE;

EID: 85043507272     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)33326-3     Document Type: Article

References (110)

1. Schottenfeld, D, Fraumeni, JF, (eds.) Cancer epidemiology and prevention, 3rd edn., 2006, Oxford University Press, Oxford.
2. International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Default.aspx (accessed Sept 25, 2017).
3. WHO. Cancer prevention and control in the context of an integrated approach: report by the Secretariat. 2016, World Health Organization, Geneva.
4. WHO. Cancer prevention and control [WHA 58.22]. 2017, World Health Organization, Geneva.
5. Vázquez, TR, Ghebreyesus, TA, Beating NCDs can help deliver universal health coverage. Lancet 390 (2017), 1473–1474.
6. Allemani, C, Weir, HK, Carreira, H, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385 (2015), 977–1010.
7. Harlan, LC, Warren, JL, Global survival patterns: potential for cancer control. Lancet 385 (2015), 926–928.
8. Centers for Disease Control and Prevention. Cancer survival: the start of global surveillance. https://www.cdc.gov/cancer/dcpc/research/articles/CONCORD-2.htm, 2015 (accessed Nov 1, 2017).
9. Walters, S, Benitez-Majano, S, Muller, P, et al. Is England closing the international gap in cancer survival?. Br J Cancer 113 (2015), 848–860.
10. Independent Cancer Taskforce. Achieving world-class cancer outcomes: a strategy for England 2015–2020. 2015, NHS England, London.
11. International Atomic Energy Agency. Access to cancer therapy. https://www.youtube.com/watch?v=cXJ79_hxdNA, Nov 20, 2015 (accessed Nov 1, 2017).
12. International Atomic Energy Agency. PACT's new campaign raises awareness of the persistent inequalities in access to lifesaving cancer services: PACT highlights the growing global divide in cancer survival rates. https://cancer.iaea.org/newsstory.asp?id=167, Sept 11, 2015 (accessed Nov 1, 2017).
13. Weir, HK, Stewart, S, Allemani, C, et al. Population-based cancer survival (2001–2009) in the United States: findings from the CONCORD-2 study. Cancer 123 (2017), 4963–4968.
14. Allemani, C, Coleman, MP, Public health surveillance of cancer survival in the US and world-wide: the contribution of the CONCORD programme. Cancer 123 (2017), 4977–4981.
15. Ferlay, J, Soerjomataram, I, Dikshit, R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (2015), E359–E386.
16. UN Statistical Division. Standard country or area codes for statistical use (M49). https://unstats.un.org/unsd/methodology/m49/, 2015 (accessed Sept 1, 2017).
17. Fritz, AG, Percy, C, Jack, A, (eds.) International classification of diseases for oncology (ICD-O), 3rd edn., 2000, World Health Organization, Geneva.
18. Fritz, AG, Percy, C, Jack, A, (eds.) International Classification of diseases for oncology (ICD-O), first revision of 3rd edn., 2013, World Health Organization, Geneva.
19. Sant, M, Karjalainen-Lindsberg, ML, Maynadié M, et al. Manual for coding and reporting haematological malignancies. Tumori, 96, 2010, i-A32.
20. Steliarova-Foucher, E, Stiller, C, Lacour, B, Kaatsch, P, International classification of childhood cancer. 3rd edn Cancer 103 (2005), 1457–1467.
21. Matz, M, Coleman, MP, Sant, M, et al. The histology of ovarian cancer: world-wide distribution and implications for international survival comparisons (CONCORD-2). Gynecol Oncol 144 (2017), 405–413.
22. Morton, LM, Turner, JJ, Cerhan, JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 110 (2007), 695–708.
23. Turner, JJ, Morton, LM, Linet, MS, et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood 116 (2010), e90–e98.
24. Woods, LM, Rachet, B, Ellis, L, Coleman, MP, Full dates (day, month, year) should be used in population-based cancer survival studies. Int J Cancer 131 (2012), E1120–E1124.
25. Surveillance Epidemiology and End Results program. Multiple primary and histology coding rules manual. 2013, National Cancer Institute, Bethesda, MD.
26. IARC Working Group. International rules for multiple primary cancers. (ICD-O 3rd edn) Eur J Cancer Prev 14 (2005), 307–308.
27. Environmental Systems Research Institute. ArcGIS desktop: release 10.3. http://desktop.arcgis.com/en/arcmap/10.3/main/get-started/whats-new-in-arcgis.htm, 2015 (accessed June 1, 2017).
28. United Nations. World population prospects: the 2015 revision. 2015, Department of Economic and Social Affairs, Population Division http://esa.un.org/unpd/wpp/ (accessed Jan 10, 2017).
29. Allemani, C, Harewood, R, Johnson, C, et al. Population-based cancer survival in the US: data, quality control and statistical methods. Cancer 123 (2017), 4982–4993.
30. Estève, J, Benhamou, E, Raymond, L, Statistical methods in cancer research, volume IV. Descriptive epidemiology (IARC Scientific Publications no. 128). 1994, International Agency for Research on Cancer, Lyon.
31. Cutler, SJ, Ederer, F, Maximum utilisation of the life table method in analyzing survival. J Chronic Dis 8 (1958), 699–712.
32. Brenner, H, Gefeller, O, An alternative approach to monitoring cancer patient survival. Cancer 78 (1996), 2004–2010.
33. Brenner, H, Spix, C, Combining cohort and period methods for retrospective time trend analyses of long-term cancer patient survival rates. Br J Cancer 89 (2003), 1260–1265.
34. Pohar Perme, M, Stare, J, Estève, J, On estimation in relative survival. Biometrics 68 (2012), 113–120.
35. Clerc-Urmès, I, Grzebyk, M, Hédelin, G, Net survival estimation with stns. Stata J 14 (2014), 87–102.
36. Rachet, B, Maringe, C, Woods, LM, Ellis, L, Spika, D, Allemani, C, Multivariable flexible modelling for estimating complete, smoothed life tables for sub-national populations. BMC Public Health, 15, 2015, 1240.
37. Micheli, A, Baili, P, Mugno, E, et al. Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. Ann Oncol 14:suppl 5 (2003), 28–40.
38. Ewbank, DC, Gómez de León, JC, Stoto, MA, A reducible four-parameter system of model life tables. Popul Studies 37 (1983), 105–129.
39. Brass, W, On the scale of mortality. Brass, W, (eds.) Biological aspects of demography, 1971, Taylor and Francis, London, 69–110.
40. Elandt-Johnson, RC, Johnson, NL, Survival models and data analysis (Wiley series in probability and mathematical statistics). 1980, John Wiley & Sons, Indianapolis, IN.
41. Corazziari, I, Quinn, MJ, Capocaccia, R, Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40 (2004), 2307–2316.
42. Stiller, CA, Bunch, KJ, Trends in survival for childhood cancer in Britain diagnosed 1971–85. Br J Cancer 62 (1990), 806–865.
43. Greenwood, M, The natural duration of cancer. Report on public health and medical subjects no. 33. 1926, HM Stationery Office, London.
44. Berkson, J, Gage, RP, Survival curve for cancer patients following treatment. J Am Stat Assoc 47 (1952), 501–515.
45. Dickman, PW, Adami, HO, Interpreting trends in cancer patient survival. J Intern Med 260 (2006), 103–117.
46. Coleman, MP, Cancer survival: global surveillance will stimulate health policy and improve equity. Lancet 383 (2014), 564–573.
47. Allemani C. The importance of global surveillance of cancer survival for cancer control: the CONCORD programme. Cancer Control (in press).
48. Abdel-Rahman, MA, Stockton, DL, Rachet, B, Hakulinen, T, Coleman, MP, What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?. Br J Cancer 101:suppl 2 (2009), 115–124.
49. Ellis, L, Coleman, MP, Rachet, B, How many deaths would be avoidable if socioeconomic inequalities in cancer survival in England were eliminated? A national population-based study, 1996–2006. Eur J Cancer 48 (2012), 270–278.
50. Ho, GF, Taib, NA, Pritam Singh, RK, Yip, CH, Abdullah, MM, Lim, TO, What if all patients with breast cancer in Malaysia have access to the best available care: how many deaths are avoidable?. Glob J Health Sci 9 (2017), 32–39.
51. Pokhrel, A, Martikainen, P, Pukkala, E, Rautalahti, M, Seppä K, Hakulinen, T, Education, survival and avoidable deaths in cancer patients in Finland. Br J Cancer 103 (2010), 1009–1114.
52. Sandiford, P, Abdel-Rahman, ME, Allemani, C, Coleman, MP, Gala, G, How many cancer deaths could New Zealand avoid if five-year relative survival ratios were the same as in Australia?. Aust NZ J Public Health 39 (2015), 157–161.
53. Seppä K, Hakulinen, T, Läärä E, Avoidable deaths and random variation in patients' survival. Br J Cancer 106 (2012), 1846–1849.
54. Mirzaei, M, Mirzadeh, M, Mirzaei, M, Expected years of life lost due to adult cancer mortality in Yazd (2004–2010). Asian Pac J Cancer Prev 17 (2016), 101–105.
55. Brustugun, OT, Møller, B, Helland, Å Years of life lost as a measure of cancer burden on a national level. Br J Cancer 111 (2014), 1014–1020.
56. Soerjomataram, I, Lortet-Tieulent, J, Parkin, DM, et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 380 (2012), 1840–1850.
57. Woods, LM, Morris, M, Rachet, B, No ‘cure’ within 12 years of diagnosis among breast cancer patients who are diagnosed via mammographic screening: women diagnosed in the West Midlands region of England 1989–2011. Ann Oncol 27 (2016), 2025–2031.
58. Andersson, TML, Eriksson, H, Hansson, J, et al. Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study. Cancer Epidemiol 38 (2014), 93–99.
59. Gatta, G, Rossi, S, Foschi, R, et al. Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002. Haematologica 98 (2013), 744–752.
60. Ito, Y, Nakayama, T, Tsukuma, H, et al. Role of age and tumour stage in the temporal pattern of ‘cure’ from stomach cancer: a population-based study in Osaka, Japan. Cancer Epidemiol 36 (2012), 128–132.
61. Shack, LG, Shah, A, Lambert, P, Rachet, B, “Cure” by age and stage at diagnosis for colorectal cancer patients: a population-based study. Cancer Epidemiol 36 (2012), 548–553.
62. Coleman, MP, Why we need global surveillance of cancer survival: the CONCORD programme. McGrath, I, (eds.) Cancer care in emerging health systems, 2013, International Network for Cancer Treatment and Research, Oxford, 60–65.
63. Cookson, JB, Cancer survival. Lancet, 356, 2000, 1611.
64. OECD. Cancer care: assuring quality to improve survival. 2013, Organisation for Economic Co-operation and Development, Paris.
65. Atun, R, Jaffray, DA, Barton, MB, et al. Expanding global access to radiotherapy. Lancet Oncol 16 (2015), 1153–1186.
66. Meara, JG, Leather, AJM, Hagander, L, et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet 386 (2015), 569–624.
67. OECD. Health at a glance 2017: OECD indicators. 2017, Organisation for Economic Co-operation and Development, Paris.
68. UICC. World Cancer Declaration 2013. 2013, Union for International Cancer Control, Geneva.
69. Jensen, OM, Parkin, DM, MacLennan, R, Muir, CS, Skeet, RG, (eds.) Cancer registration: principles and methods (IARC Scientific Publications no. 95), 1991, International Agency for Research on Cancer, Lyon.
70. Berrino, F, Estève, J, Coleman, MP, Basic issues in the estimation and comparison of cancer patient survival. Berrino, F, Sant, M, Verdecchia, A, Capocaccia, R, Hakulinen, T, Estève, J, (eds.) Survival of cancer patients in Europe: the EUROCARE study (IARC Scientific Publications no. 132), 1995, International Agency for Research on Cancer (WHO), Lyon, 1–14.
71. Abdel-Razeq, H, Attiga, F, Mansour, A, Cancer care in Jordan. Hematol Oncol Stem Cell Ther 8 (2015), 64–70.
72. Laurenti, R, Coleman, MP, Aylin, P, Accuracy of statements of the cause of death on death certificates and the international comparability of mortality statistics. Coleman, MP, Aylin, P, (eds.) Death certification and mortality statistics: an international perspective, 2000, Office for National Statistics, London, 1–9.
73. Ovcharov, VK, Tishuk, EA, The improvement of statistical records of the causes of death in Russia. Coleman, MP, Aylin, P, (eds.) Death certification and mortality statistics: an international perspective, 2000, Office for National Statistics, London, 28–30.
74. Filippatos, G, Andriopoulos, P, Panoutsopoulos, G, et al. The quality of death certification practice in Greece. Hippokratia 20 (2016), 19–25.
75. Haghighi, MH, Dehghani, M, Teshizi, SH, Mahmoodi, H, Impact of documentation errors on accuracy of cause of death coding in an educational hospital in Southern Iran. HIM J 43 (2014), 35–42.
76. Cândida da Cunha, C, Teixeira, R, França, E, Assessment of the investigation of ill-defined causes of death in Brazil in 2010. Epidemiol Serv Saude 26 (2017), 1–12.
77. Antoni, S, Soerjomataram, I, Møller, B, Bray, F, Ferlay, J, An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence. Bull World Health Organ 94 (2016), 174–184.
78. Engeland, A, Haldorsen, T, Dickman, PW, et al. Relative survival of cancer patients: a comparison between Denmark and other Nordic countries. Acta Oncol 37 (1998), 49–59.
79. Berrino, F, Capocaccia, R, Estève, J, et al. (eds.) Survival of cancer patients in Europe: the EUROCARE-2 study (IARC Scientific Publications no. 151), 1999, International Agency for Research on Cancer, Lyon.
80. Storm, HH, Gislum, M, Engholm, G, Cancer survival before and after initiating the Danish Cancer Control plan. Ugeskr Læger 170 (2008), 3065–3069 (in Danish).
81. Engholm, G, Ferlay, J, Christensen, N, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic Countries, version 7.3 (08.07.2016). 2016, Association of the Nordic Cancer Registries, Danish Cancer Society http://www.ancr.nu (accessed Nov 3, 2017).
82. Storm, HH, Engholm, G, Hakulinen, T, et al. Survival of patients diagnosed with cancer in the Nordic countries up to 1999-2003 followed to the end of 2006. A critical overview of the results. Acta Oncol 49 (2010), 532–544.
83. Yoo, KY, Cancer control activities in the Republic of Korea. Jpn J Clin Oncol 38 (2008), 327–333.
84. Choi, KS, Jun, JK, Suh, M, et al. Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea. Br J Cancer 112 (2015), 608–612.
85. Pech, O, May, A, Manner, H, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146 (2014), 652–660.
86. Suh, YS, Yang, HK, Screening and early detection of gastric cancer: East versus West. Surg Clin North Am 95 (2015), 1053–1066.
87. Chang, JW-C, Guo, J, Hung, C-Y, et al. Sunrise in melanoma management: time to focus on melanoma burden in Asia. Asia Pac J Clin Oncol 13 (2017), 423–427.
88. Brawley, OW, Accepting the existence of breast cancer overdiagnosis. Ann Intern Med 166 (2017), 364–365.
89. Marcus, PM, Prorok, PC, Miller, AB, DeVoto, EJ, Kramer, BS, Conceptualizing overdiagnosis in cancer screening. J Natl Cancer Inst 107 (2015), 1–4.
90. Allemani, C, Rachet, B, Weir, HK, et al. Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study. BMJ Open, 3, 2013, e003055.
91. Maringe, C, Walters, S, Rachet, B, et al. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000–2007. Acta Oncol 52 (2013), 919–932.
92. Wu, SJ, Chiang, CJ, Lin, CT, Tien, HF, Lai, MS, Improving but inferior survival in patients with chronic lymphocytic leukemia in Taiwan: a population-based study, 1990–2004. PLoS One, 8, 2013, e62930.
93. Sullivan, R, Kowalczyk, JR, Agarwal, B, et al. New policies to address the global burden of childhood cancers. Lancet Oncol 14 (2013), e125–e135.
94. Magrath, I, Steliarova-Foucher, E, Epelman, S, et al. Paediatric cancer in low-income and middle-income countries. Lancet Oncol 14 (2013), e104–e116.
95. Mostert, S, Arora, RS, Arreola, M, et al. Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group. Lancet Oncol 12 (2011), 719–720.
96. Pritchard-Jones, K, Stiller, CA, What can we learn from geographical comparisons of childhood cancer survival?. Br J Cancer 96 (2007), 1493–1497.
97. Ginsburg, O, Bray, F, Coleman, MP, et al. The global burden of women's cancers: a grand challenge in global health. Lancet 389 (2017), 847–860.
98. Ginsburg, O, Badwe, R, Boyle, P, et al. Changing global policy to deliver safe, equitable and affordable care for women's cancers. Lancet 389 (2017), 871–880.
99. Beaulieu, N, Bloom, D, Bloom, R, Stein, R, Breakaway: the global burden of cancer—challenges and opportunities. A report from the Economist Intelligence Unit. 2009, The Economist, London.
100. Mariotto, AB, Yabroff, KR, Shao, Y, Feuer, EJ, Brown, ML, Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst 103 (2011), 117–128.
101. Fojo, T, Grady, C, How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question. J Natl Cancer Inst 101 (2009), 1044–1048.
102. Knaul, FM, Gralow, J, Atun, R, Bhadelia, A, Closing the cancer divide: an equity imperative. 2011, Harvard University Press, Boston, MA.
103. Sullivan, R, Peppercorn, J, Sikora, K, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol 12 (2011), 933–980.
104. Tangka, FKL, Subramanian, S, Beebe, MC, et al. Cost of operating central cancer registries and factors that affect cost: findings from an economic evaluation of Centers for Disease Control and Prevention National Program of Cancer Registries. J Public Health Manag Pract 22 (2016), 452–460.
105. United Nations. Sustainable Development Goals. http://www.un.org/sustainabledevelopment/sustainable-development-goals/, 2015 (accessed Sept 25, 2017).
106. United Nations. Sustainable Development Goal 3. https://sustainabledevelopment.un.org/sdg3, 2015 (accessed Sept 25, 2017).
107. Schmidt, H, Gostin, LO, Emanuel, EJ, Public health, universal health coverage, and sustainable development goals: can they coexist?. Lancet 386 (2015), 928–930.
108. López, A, Thomason, J, Civil registration and vital statistics—everybody's business but nobody's business. Lancet 381 (2013), 1275–1276.
109. Setel, PW, Macfarlane, SB, Szreter, S, et al. Who counts? 1: A scandal of invisibility: making everyone count by counting everyone. Lancet 370 (2007), 1569–1577.
110. WHO. Cancer prevention and control in the context of an integrated approach [A70/A/CONF./9]. 2017, World Health Organization, Geneva.